0001209191-14-030917.txt : 20140502 0001209191-14-030917.hdr.sgml : 20140502 20140502200029 ACCESSION NUMBER: 0001209191-14-030917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140501 FILED AS OF DATE: 20140502 DATE AS OF CHANGE: 20140502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gregory Philip D CENTRAL INDEX KEY: 0001343543 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 14811025 MAIL ADDRESS: STREET 1: POINT RICHMOND TECH CENTER II STREET 2: 501 CANAL BOULEVARD SUITE A100 CITY: RICHMOND STATE: CA ZIP: 94804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-05-01 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001343543 Gregory Philip D C/O SANGAMO BIOSCIENCES INC., POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 0 1 0 0 SVP of Research & CSO Common Stock 2014-05-01 4 M 0 7000 6.82 A 116347 D Common Stock 2014-05-01 4 M 0 3000 3.45 A 119347 D Common Stock 2014-05-01 4 M 0 5000 5.35 A 124347 D Common Stock 2014-05-01 4 S 0 15000 13.6786 D 109347 D Employee Stock Option (Right to Buy) 6.82 2014-05-01 4 M 0 7000 0.00 D 2016-12-12 Common Stock 7000 37000 D Employee Stock Option (Right to Buy) 3.45 2014-05-01 4 M 0 3000 0.00 D 2018-12-09 Common Stock 3000 55500 D Employee Stock Option (Right to Buy) 5.35 2014-05-01 4 M 0 5000 0.00 D 2019-12-06 Common Stock 5000 85000 D Includes 33,333 shares, 26,666 shares, and 35,000 shares subject to restricted stock units granted on December 8, 2011, December 6, 2012, and December 12, 2013 respectively, which will be issued as such units vest in accordance with their terms. The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2014. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.47 to $14.00, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. All shares underlying this option are vested and immediately exercisable. /s/ Florence Tam, attorney-in-fact 2014-05-02